Aspire Biopharma raises $2M via 8% OID debentures with 790K incentive shares

Aspire Biopharma Holdings, Inc.

Issued $2,173,913 principal of 8% OID debentures for $2,000,000; maturity sooner of 90 days or $8M financing event.
Debentures are non-convertible, bear no interest; 790,000 shares of common stock issued as incentive shares.
Proceeds to be used for debt repayment and working capital; offering exempt under Section 4(a)(2).

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.